| 高雄醫學大學 |
2007 |
干安能治療B型肝炎引起失償非肝硬化病患早期死亡率及反應-以MELD及INDEX指標評估
|
戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
The antinuclear antibody is associated with lower RNA levels of hepatitis C virus and more advanced fibrosis in chronic hepatitis C patients
|
謝明彥;黃志富;侯乃仁;戴嘉言;李立柏;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍;余明隆 |
| 高雄醫學大學 |
2007 |
Almost all HCV G2 Pts With Rapid Virologic Response at Wk 4 Achieve a SVR With 16 Wks of Treatment
|
余明隆;戴嘉言;黃志富;侯乃仁;李立柏;謝明彥;丘長富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
Evaluation of the Abbott HCV RealTime PCR Assay for quantification of HCV viral loads
|
莊萬龍;黃志富;余明隆;戴嘉言;李立柏;謝明彥;林子堯;陳信成;謝明裕;張文宇 |
| 高雄醫學大學 |
2007 |
Different Features In Liver Histopathology Of HCV Monoinfection And HCV/HBV Dual Infection
|
李立柏;余明隆;戴嘉言;侯乃仁;謝明彥;林子堯;陳信成;謝明裕;王良彥;Chen, Tong-Jong;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
Transforming Growth Factor-Beta 1 Gene Polymorphisms In High Dose IFN/Ribavirin treated CHC Patients
|
戴嘉言;余明隆;張文宇;李立柏;潘文正;侯乃仁;謝明彥;黃志富;陳信成;林子堯;謝明裕;王良彥;莊萬龍 |
| 高雄醫學大學 |
2007 |
EARLY MORTALITY AND RESPONSES IN NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B-RELATED DECOMPENSATION WITH LAMIVUDINE THERAPY: EVALUATION OF MELD AND INDEX SCORING SYSTEMS AS PROGNOSTIC PREDICTORS
|
戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2007 |
High chance of cure in HCV genotype 1 patients with a low viral load achieving an RVR treated for 24 wks with pegylated interferon alfa-2a (PEGASYS) plus ribavirin (COPEGUS): Prospective, randomized, controlled study comparing 24 & 48 wks of treatm
|
余明隆;戴嘉言;黃志富;李立柏;謝明彥;丘長富;侯乃仁;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍* |
| 高雄醫學大學 |
2007 |
RELATIONSHIP BETWEEN GLUCOSE ABNORMALITIES AND RESPONSE TO PEGYLATED INTERFERON ALFA PLUS RIBAVIRIN COMBINATION THERAPY IN CHRONIC HEPATITIS C PATIENTS
|
謝明彥;戴嘉言;黃志富;林子堯;余明隆;莊萬龍 |
| 中國文化大學 |
2006 |
健康體適能俱樂部區位選址模式之研究—以高雄地區為例
|
林子堯 |
| 國立臺灣體育運動大學 |
2006 |
舉重選手體型、肌力與成績表現相關研究
|
林子堯; Lin, Tzu-Yao |
| 高雄醫學大學 |
2006 |
Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
|
林子堯;莊萬龍;莊豔凰;余明隆;謝明裕;王良彥;蔡榮發 ; Zu-Yau Lin;Wan-Long Chuang;Yen-Huang Chuang;Ming-Lung Yu;Ming-Yuh Hsieh;Liang-Yen Wang;Jung-Fa Tsai |
| 高雄醫學大學 |
2006 |
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
|
余明隆;林錫銘;李全謨;戴嘉言;張文宇;陳信成;李立柏;林子堯;謝明裕;王良彥;莊萬龍;廖運範 ; Yu ML;Lin SM;Lee CM;Dai CY;Chang WY;Chen SC;Lee LP;Lin ZY;Hsieh MY;Wang LY;Chuang WL;Liaw YF |
| 高雄醫學大學 |
2006 |
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.
|
余明隆;戴嘉言;李立柏;謝明彥;侯乃仁;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 ; Yu ML;Dai CY;Lee LP;Hsieh MY;Hou NJ;Huang JF;Lin ZY;Chen SC;Hsieh MY;Wang LY;Chang WY;Chuang WL |
| 高雄醫學大學 |
2006 |
The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
|
黃志富;莊萬龍;戴嘉言;陳信成;林子堯;李立柏;王良彥;謝明裕;張文宇;余明隆 ; Jee-Fu Huang;Wan-Long Chuang;Chia-Yen Dai;Shinn-Cherng Chen;Zu-Yau Lin;Li-Po Lee;Liang-Yen Wang;Ming-Yuh Hsieh;Wen-Yu Chang;Ming-Lung Yu |
| 高雄醫學大學 |
2006 |
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.
|
戴嘉言;莊萬龍;張文宇;陳信成;李立柏;謝明彥;侯乃仁;林子堯;黃志富;謝明裕;王良彥;余明隆 ; Dai CY;Chuang WL;Chang WY;Chen SC;Lee LP;Hsieh MY;Hou NJ;Lin ZY;Huang JF;Hsieh MY;Wang LY;Yu ML |
| 高雄醫學大學 |
2006 |
Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?
|
黃志富;莊萬龍;戴嘉言;何啟功;黃尚志;陳信成;林子堯;王良彥;張文宇; , 余明隆; Huang, JF;Chuang, WL;Dai, CY;Ho, CK;Hwang, SJ;Chen, SC;Lin, ZY;Wang, LY;Chang, WY; , Yu ML |
| 高雄醫學大學 |
2006 |
A randomized study of peginterferon and ribavirin for 16 vs 24 weeks in patients with genotype 2 chronic hepatitis C
|
余明隆;戴嘉言;黃志富;侯乃仁;李立柏;謝明彥;丘長富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2006 |
Predictors for early mortality in lamivudine-treated patients with chronic hepatitis B-related decompensation in Taiwan ”has been accepted for poster presentation at the forthcoming.
|
戴嘉言;莊萬龍;李立柏;謝明裕;侯乃仁;陳信成;林子堯;謝明彥;王良彥;黃志富;張文宇;余明隆 |
| 高雄醫學大學 |
2006 |
CLINICAL SIGNIFICANCE OF ERYTHROPOIETIN IN CHRONIC HEPATITIS C PATIENTS
|
侯乃仁;余明隆;戴嘉言;林子堯;張文宇;莊萬龍 |
| 高雄醫學大學 |
2006 |
A randomized, controlled, open-label study of peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 vs. 24 weeks in patients with genotype 2 hepatitis C infection
|
余明隆;黃志富;侯乃仁;李立柏;謝明彥;丘長富;林子堯;陳信成;謝明彥;王良彥;張文宇;莊萬龍 |
| 高雄醫學大學 |
2006 |
Predictors for early mortality in lamivudine-treated patients with chronic hepatitis B-related decompensation in Taiwan ”has been accepted for poster presentation at the forthcoming.
|
戴嘉言;莊萬龍;李立柏;謝明裕;侯乃仁;陳信成;林子堯;謝明彥;王良彥;黃志富;張文宇;余明隆 |
| 高雄醫學大學 |
2005 |
Safety of fine-needle aspiration in patients with small hepatocellular carcinoma.
|
王志文;林子堯;莊萬龍;王良彥;余明隆;陳信成;謝明裕;蔡榮發;張文宇 ; Wang CW;Lin ZY;Chuang WL;Wang LY;Yu ML;Chen SC;Hsieh MY;Tsai JF;Chang WY. |
| 高雄醫學大學 |
2005 |
Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma
|
蔡榮發;鄭貞英;莊麗月;尤慧玲;王良彥;謝明裕;陳信成;莊萬龍;林子堯;余明隆;戴嘉言 ; Tsai JF;Jeng JE;Chuang LY;You HL;Wang LY;Hsieh MY;Chen SC;Chuang WL;Lin ZY;Yu ML;Dai CY |
| 高雄醫學大學 |
2005 |
第二型類胰島素生長因子做為小型肝細胞癌血清學標誌之研究
|
蔡榮發;王良彥;莊萬龍;林子堯;余明隆;戴嘉言 |
